NAMSA Acquires The Integra Group, Expanding Imaging and Clinical Services

NAMSA Acquires The Integra Group, Expanding Imaging and Clinical Services

<0> For further information about NAMSA or this news release, contact:NAMSATerry Langenderfer, Director, Global Marketing, 419-662-4323 </0>

NAMSA, the world's leading medical device research organization, has acquired The Integra Group, a preclinical and clinical research organization located near Minneapolis.

The medical device research, regulatory approval and commercialization process is continuously taking longer and costing more. Having breadth and depth in consulting, non-clinical and clinical services with experts in cardiovascular, orthopedic, ocular, neurologic, gastroenterologic, urologic, combination product and related medical devices can help manufacturers accelerate these development efforts.

"NAMSA is very pleased to now be able to offer The Integra Group's imaging lab, biostatistics and physician training services along with our world-class expertise in R&D, biocompatibility and clinical research," said John Gorski, NAMSA's President and CEO. "We expect having experts in all of these areas will help clients get their products in the hands of physicians and patients who need them most to help diagnose, treat and even cure diseases around the world."

"The Integra Group has been able to execute an integrated testing model like this very well and we are excited about being able to now offer this model to our clients," said Gorski.

For clients undergoing feasibility evaluations for novel medical technologies, particularly in the cardiovascular and orthopedic areas, this acquisition will mean studies now can be completed in days or weeks, not months as in the past. Additionally, adding further consulting, materials characterization, biocompatibility and clinical services is a natural extension for Integra clients in Minneapolis.

"The medical device industry has been waiting for a consolidated service provider with this depth and breadth of expertise. This acquisition brings two complementary, world-class service providers together, giving medical device manufacturers the best of all worlds," said Chris Pulling, CEO of The Integra Group.

Both Chris Pulling and Dr. Roy Martin, Chief Medical Officer, of the Integra Group, will be part of the new NAMSA – Integra Division in Minneapolis in key executive roles.

Suggested Articles

Loretta Itri, M.D. has been helping Immunomedics out with its troubled antibody-drug conjugate. Now, she’s signing on as its chief medical officer.

Light Chain Bioscience, a unit of Swiss biotech Novimmune, has been handed a nice royalty milestone check from partner Takeda.

The fund received money from Chinese organizations inside and outside the biopharma industry, enabling CICC Capital to ease past its financing goal.